Eli Lilly (NYSE:LLY) on Friday reported plans to acquire Adverum Biotechnologies (NASDAQ:ADVM) and its lead gene therapy candidate, Ixo-vec, sending Adverum shares soaring in premarket trading. Under ...

Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...

On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The company cited strategic ...

Eli Lilly (NYSE:LLY) on Tuesday announced it will invest $5B to build a new manufacturing facility in Virginia as part of the weight loss drugmaker’s plans to add four new manufacturing sites within ...

Eli Lilly and Co. on Tuesday officially announced plans to build a $5 billion manufacturing plant just west of Richmond, Virginia, part of the Indianapolis drugmaker’s commitment to add U.S.

Lila Biologics, a startup that spun out of Nobel Laureate David Baker’s lab at the University of Washington, announced a collaboration with pharmaceutical giant Eli Lilly to develop therapies for ...

For more than six decades, Lilly Pulitzer has been synonymous with colorful, eye-catching resortwear, often featuring playful motifs. Several prints have been released over the years, but ahead of ...

Telangana Chief Minister A. Revanth Reddy inaugurated US pharma major Eli Lilly’s Global Capability Centre (GCC) in Hyderabad on Monday (August 4, 2025). After the launch, the Chief Minister described ...

As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company is moving to offload another plant with a checkered past. Lilly plans to ...

The E! Insider Shop editors and writers search the internet to find the best products out there. We interview expert sources, comb through customer reviews, and use our own personal experiences to ...

Eli Lilly LLY3.81%increase; green up pointing triangle agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.

June 16 (Reuters) - Eli Lilly (LLY.N), opens new tab will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S.